De Giles targets Musselburgh
Ed de Giles is expecting a big run from Croquembouche in the £30,000 feature race at Musselburgh on Friday.
Blog
Hayden joins Newport on loan
Newport have signed teenage Wolves defender Aaron Hayden on a youth loan.
Lloyd: Broad can target 400
Stuart Broad will “motor” towards 400 Test-match wickets after destroying Australia on day one of the fourth Ashes Test at Trent Bridge, says David Lloyd.
De Giles targets Musselburgh
Ed de Giles is expecting a big run from Croquembouche in the £30,000 feature race at Musselburgh on Friday.
Lloyd: Broad can target 400
Stuart Broad will “motor” towards 400 Test-match wickets after destroying Australia on day one of the fourth Ashes Test at Trent Bridge, says David Lloyd.
Kilimanjaro scratched from Leger
Kilimanjaro, as low as 16-1 for the Ladbrokes St Leger at Doncaster on September 12, has been officially scratched from the race by trainer Aidan O’Brien.
Kilimanjaro scratched from Leger
Kilimanjaro, as low as 16-1 for the Ladbrokes St Leger at Doncaster on September 12, has been officially scratched from the race by trainer Aidan O’Brien.
Britain raps Pfizer over huge jump in epilepsy drug price
Britain’s competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent. The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused a dominant position by charging “excessive and unfair” prices for phenytoin sodium capsules. Pfizer and
Britain raps Pfizer over huge jump in epilepsy drug price
Britain’s competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent. The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused a dominant position by charging “excessive and unfair” prices for phenytoin sodium capsules. Pfizer and
Britain raps Pfizer over huge jump in epilepsy drug price
Britain’s competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent. The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused a dominant position by charging “excessive and unfair” prices for phenytoin sodium capsules. Pfizer and